These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22914469)

  • 21. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities.
    Derby CA; Hume AL; Barbour MM; McPhillips JB; Lasater TM; Carleton RA
    Am J Epidemiol; 1993 May; 137(10):1125-35. PubMed ID: 8317442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative.
    Cirillo DJ; Wallace RB; Wu L; Yood RA
    Arthritis Rheum; 2006 Oct; 54(10):3194-204. PubMed ID: 17009251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of estrogen or estrogen-progestin hormone therapy use.
    Brett KM; Reuben CA
    Obstet Gynecol; 2003 Dec; 102(6):1240-9. PubMed ID: 14662210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
    Jonas HA; Kronmal RA; Psaty BM; Manolio TA; Meilahn EN; Tell GS; Tracy RP; Robbins JA; Anton-Culver H
    Ann Epidemiol; 1996 Jul; 6(4):314-23. PubMed ID: 8876842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
    Chlebowski RT; Wakelee H; Pettinger M; Rohan T; Liu J; Simon M; Tindle H; Messina C; Johnson K; Schwartz A; Gass M; Wactawski-Wende J
    Clin Lung Cancer; 2016 Jan; 17(1):10-7.e1. PubMed ID: 26577506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
    Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
    Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial.
    Michael YL; Gold R; Manson JE; Keast EM; Cochrane BB; Woods NF; Brzyski RG; McNeeley SG; Wallace RB
    Menopause; 2010 Mar; 17(2):295-302. PubMed ID: 19858764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006.
    Zhang D; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    Am J Kidney Dis; 2014 Feb; 63(2):198-205. PubMed ID: 24051078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menopausal hormone replacement therapy and risk of ovarian cancer.
    Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
    JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer incidence and hormone replacement therapy in Canada.
    De P; Neutel CI; Olivotto I; Morrison H
    J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES).
    Pirkle JL; Brody DJ; Gunter EW; Kramer RA; Paschal DC; Flegal KM; Matte TD
    JAMA; 1994 Jul; 272(4):284-91. PubMed ID: 8028141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom experience after discontinuing use of estrogen plus progestin.
    Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
    JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing concepts: Menopausal hormone therapy and breast cancer.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.